Valuation: Pharmena S.A.

Market Cap 34.08M 8.76M 7.79M 7.27M 6.62M 12.49M 843M 12.61M 87.95M 431M 32.9M 32.19M 1.38B P/E 2024
-33.8x
P/E 2025 -10.4x
Enterprise Value 34.09M 8.77M 7.79M 7.27M 6.63M 12.5M 843M 12.61M 87.98M 431M 32.91M 32.2M 1.38B EV / Sales 2024
154x
EV / Sales 2025 18.4x
Free-Float
29.7%
Yield 2024 *
-
Yield 2025 -
1 week-0.97%
1 month-6.13%
3 months-3.16%
6 months-7.27%
Current year+17.69%
1 week 2.99
Extreme 2.99
3.09
1 month 2.99
Extreme 2.99
3.4
Current year 2.56
Extreme 2.56
4.32
1 year 2.5
Extreme 2.5
4.32
3 years 2.5
Extreme 2.5
9.18
5 years 2.5
Extreme 2.5
10.96
10 years 2.5
Extreme 2.5
33.48
Manager TitleAgeSince
Chief Executive Officer - 11/11/2002
Chief Tech/Sci/R&D Officer - 31/03/2008
Director TitleAgeSince
Director/Board Member 62 -
Director/Board Member 63 -
Director/Board Member 58 -
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-0.97%-15.00%-47.96% 8.76M
+0.67%-0.90%-4.83%-0.40% 337B
+0.27%-2.38%-1.01%-4.87% 223B
-0.23%-3.88%-9.26%-1.68% 128B
-0.32%-2.09%+8.03%+19.57% 67.17B
-0.16%-1.50%+14.68% - 45.15B
-2.29%-5.50%-27.86%-25.63% 44.87B
+1.97%-2.65%+4.49%-34.80% 33.27B
-0.12%-3.37%+8.79%-13.96% 33.04B
+0.02%-4.13%-23.02%-21.73% 31.38B
Average -0.02%-2.57%-4.50%-14.61% 94.25B
Weighted average by Cap. +0.20%-2.18%-3.57%-3.98%

Financials

2024 2025
Net sales 268K 68.92K 61.23K 57.15K 52.09K 98.24K 6.63M 99.16K 692K 3.39M 259K 253K 10.87M 1.58M 406K 360K 336K 307K 578K 38.98M 583K 4.07M 19.93M 1.52M 1.49M 63.96M
Net income -1.26M -325K -288K -269K -245K -463K -31.2M -467K -3.26M -15.95M -1.22M -1.19M -51.18M -2.77M -712K -633K -590K -538K -1.02M -68.45M -1.02M -7.15M -34.99M -2.67M -2.62M -112M
Net Debt -1.5M -386K -343K -320K -292K -550K -37.11M -555K -3.87M -18.97M -1.45M -1.42M -60.88M 9K 2.31K 2.06K 1.92K 1.75K 3.3K 222K 3.33K 23.23K 114K 8.69K 8.5K 365K
Logo Pharmena S.A.
Pharmena SA is a Poland-based producer of cosmetics and pharmaceuticals. The Company’s products range encompasses Dermena, a line of products against hair loss; Dermena Plus, a shampoo reducing the symptoms of dandruff and preventing excessive hair loss; Accos, an anti-acne gel; Allerco, a line of hypo-allergic emollients for body care, Thermi, a gel after thermal burn and sunburn; and Revium, a line of anti-wrinkle treatment products. Pharmena SA maintains multidirectional research works and application studies in conjunction with a number of research centers in Europe, the United States and Canada. As of December 31, 2011, the Company had one wholly owned subsidiary, Cortria Corporation, based in the United States. As of December 31, 2011, Polska Grupa Farmaceutyczna SA held a 43.65% stake in the capital. The main shareholder of the Company is Pelion SA.
Employees
7
Date Price Change Volume
02/10/26 PLN 3.060 0.00% 3,182
01/10/26 PLN 3.060 0.00% 690
30/09/26 PLN 3.060 -0.33% 1,502
29/09/26 PLN 3.070 -0.32% 431
28/09/26 PLN 3.080 -0.32% 690